Cannabis Science Product Line To Feature Proprietary Medical Formulations For Chronic Pain, Fibromyalgia

Cannabis Science Product Line To Feature Proprietary Medical Formulations For Chronic Pain, Fibromyalgia
Colorado Springs, Colorado based Cannabis Science, Inc., a company specializing in cannabis-based drug development and related consulting work, has announced readiness to release its first line of European medicinal cannabis products at Spannabis 2015, to be held at Barcelona, Spain, from March 20th — 22nd. These medicines will incorporate Cannabis Science proprietary formulations developed in Spain and the Netherlands. The company's product pipeline addresses a wide range of diseases and symptoms, including Chronic Pain and Fibromyalgia. Spannabis, the world's largest Cannabis conference, has been held in Barcelona since 2004. At last year's conference, 500 companies were represented, and 33.000 visitors attended from Belgium, Canada, China, France , Germany, Hungary, Ireland, Italy, Poland, Russia. Slovenia, Spain, Switzerland, The Netherlands, United Kingdom, and the USA. The 2015 meetings will be Cannabis Science's first time exhibiting at the internationally acclaimed conference. "We are delighted to be attending Spannabis and showcasing our products that have been in drug development pipeline for the last two years, after rigorous testing we are excited to show them to Spain and the rest of the world," the company notes in a release. Cannabis Science, Inc. launched its toll-free call center in preparation for multiple global product launches that took place on March 3. Company CEO, President & Co-Founder Raymond C. Dabney also recently shared his thoughts on the burgeoning medical cannabis industry with Chicago HR Examiner columnist Pam C. Waits, discussing the company's goals and directional focus, and relating how Cannabis Science is helping build awareness of medical cannabis products' effectiveness, and how it is working toward bringing
Subscribe or to access all post and page content.